SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007465
Filing Date
2024-05-09
Accepted
2024-05-09 07:17:44
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20240331x10q.htm   iXBRL 10-Q 1746705
2 EX-10.5 aplt-20240331xex10d5.htm EX-10.5 271476
3 EX-31.1 aplt-20240331xex31d1.htm EX-31.1 9303
4 EX-31.2 aplt-20240331xex31d2.htm EX-31.2 9324
5 EX-32.1 aplt-20240331xex32d1.htm EX-32.1 5829
6 EX-32.2 aplt-20240331xex32d2.htm EX-32.2 5926
  Complete submission text file 0001558370-24-007465.txt   8168214

Data Files

Seq Description Document Type Size
7 EX-101.SCH aplt-20240331.xsd EX-101.SCH 67565
8 EX-101.CAL aplt-20240331_cal.xml EX-101.CAL 42557
9 EX-101.DEF aplt-20240331_def.xml EX-101.DEF 304134
10 EX-101.LAB aplt-20240331_lab.xml EX-101.LAB 500067
11 EX-101.PRE aplt-20240331_pre.xml EX-101.PRE 489655
91 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20240331x10q_htm.xml XML 1141465
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 24928552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)